Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-07-17 Sale |
2025-07-18 4:12 pm |
JOHNSON & JOHNSON | JNJ | REED JOHN C EVP, Innovative Medicine, R&D |
19,137 | $163.55 | $3,129,830 | 10,658 (Direct) |
View |
| 2024-04-30 Purchase |
2025-02-28 7:05 pm |
JOHNSON & JOHNSON | JNJ | Woods Eugene A. Director |
100 | $145.53 | $14,553 | 400 (Indirect) |
View |
| 2025-02-25 Sale |
2025-02-26 6:42 pm |
JOHNSON & JOHNSON | JNJ | Decker Robert J VP Corporate Controller |
6,999 | $165.88 | $1,160,994 | 21,755 (Indirect Direct) |
View |
| 2025-02-18 Sale |
2025-02-18 9:33 pm |
JOHNSON & JOHNSON | JNJ | Schmid Timothy EVP, WW Chair, MedTech |
403 | $156.15 | $62,928 | 17,653 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2025-07-08 5:31 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Pinto Daniel E Director |
0 | $0 | 0 (Direct) |
View |
| 2025-06-10 Option Award |
2025-06-12 4:32 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | HEWSON MARILLYN A Director |
322 | $155.23 | 13,438 (Direct) |
View |
| 2025-06-10 Option Award |
2025-06-12 4:30 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Woods Eugene A. Director |
231 | $155.23 | 4,597 (Direct) |
View |
| 2025-05-01 Tax Withholding |
2025-05-05 5:10 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | REED JOHN C EVP, Innovative Medicine, R&D |
11,002 | $156.31 | 55,050 (Direct) |
View |
| 2025-05-01 Exercise |
2025-05-05 5:10 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | REED JOHN C EVP, Innovative Medicine, R&D |
25,255 | $0 | 55,050 (Direct) |
View |
| 2025-04-24 Option Award |
2025-04-28 5:57 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Woods Eugene A. Director |
1,316 | $0 | 4,330 (Direct) |
View |
| 2025-04-24 Option Award |
2025-04-28 5:54 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | West Nadja Director |
1,316 | $0 | 6,573 (Direct) |
View |
| 2025-04-24 Option Award |
2025-04-28 5:52 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | WEINBERGER MARK A Director |
1,316 | $0 | 10,737 (Direct) |
View |
| 2025-04-24 Option Award |
2025-04-28 5:50 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | McClellan Mark B. Director |
1,316 | $0 | 19,755 (Direct) |
View |
| 2025-04-24 Option Award |
2025-04-28 5:48 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Joly Hubert Director |
1,316 | $0 | 7,987 (Direct) |
View |
| 2025-04-24 Option Award |
2025-04-28 5:45 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Johnson Paula A Director |
1,316 | $0 | 4,266 (Direct) |
View |
| 2025-04-24 Option Award |
2025-04-28 5:41 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | HEWSON MARILLYN A Director |
1,316 | $0 | 13,007 (Direct) |
View |
| 2025-04-24 Option Award |
2025-04-28 5:39 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Beckerle Mary C Director |
1,316 | $0 | 15,395 (Direct) |
View |
| 2025-04-24 Option Award |
2025-04-28 5:38 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Doudna Jennifer A Director |
1,316 | $0 | 9,656 (Direct) |
View |
| 2025-03-18 Gift |
2025-03-19 8:07 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO and Chairman of the Board |
130,852 | $0 | 407,782 (Direct) |
View |
| 2025-03-04 Option Award |
2025-03-06 4:42 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | HEWSON MARILLYN A Director |
226 | $166.1 | 11,691 (Direct) |
View |
| 2025-03-04 Option Award |
2025-03-06 4:38 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Woods Eugene A. Director |
188 | $166.1 | 3,014 (Direct) |
View |
Ownership |
2025-02-28 7:05 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Woods Eugene A. Director |
0 | $0 | 400 (Indirect) |
View |
| 2025-02-25 Exercise |
2025-02-26 6:42 pm |
2019-02-09 2026-02-08 |
JOHNSON & JOHNSON | JNJ | Decker Robert J VP Corporate Controller |
6,999 | $101.87 | 21,755 (Direct) |
View |
| 2025-02-15 Option Award |
2025-02-19 5:44 pm |
N/A 2035-02-15 |
JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO |
96,909 | $0 | 96,909 (Direct) |
View |
| 2025-02-15 Option Award |
2025-02-19 5:37 pm |
N/A 2035-02-15 |
JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief TO and Risk Officer |
32,744 | $0 | 32,744 (Direct) |
View |
| 2025-02-15 Option Award |
2025-02-19 5:35 pm |
N/A 2035-02-15 |
JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WWC. Innovative Medicine |
95,320 | $0 | 95,320 (Direct) |
View |
| 2025-02-15 Option Award |
2025-02-19 5:33 pm |
N/A 2035-02-15 |
JOHNSON & JOHNSON | JNJ | Swanson James D. EVP, CIO |
36,603 | $0 | 36,603 (Direct) |
View |
| 2025-02-15 Option Award |
2025-02-19 5:31 pm |
N/A 2035-02-15 |
JOHNSON & JOHNSON | JNJ | Schmid Timothy EVP, WW Chair, MedTech |
52,955 | $0 | 52,955 (Direct) |
View |
| 2025-02-15 Option Award |
2025-02-19 5:29 pm |
N/A 2035-02-15 |
JOHNSON & JOHNSON | JNJ | REED JOHN C EVP, Innovative Medicine, R&D |
95,320 | $0 | 95,320 (Direct) |
View |
| 2025-02-15 Option Award |
2025-02-19 5:27 pm |
N/A 2035-02-15 |
JOHNSON & JOHNSON | JNJ | Mulholland Kristen EVP, Chief HR Officer |
29,676 | $0 | 29,676 (Direct) |
View |
| 2025-02-15 Option Award |
2025-02-19 5:25 pm |
N/A 2035-02-15 |
JOHNSON & JOHNSON | JNJ | Forminard Elizabeth Executive VP, General Counsel |
54,877 | $0 | 54,877 (Direct) |
View |
| 2025-02-15 Option Award |
2025-02-19 5:22 pm |
N/A 2035-02-15 |
JOHNSON & JOHNSON | JNJ | Decker Robert J VP Corporate Controller |
9,388 | $0 | 9,388 (Direct) |
View |
| 2025-02-15 Option Award |
2025-02-19 5:18 pm |
N/A 2035-02-15 |
JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO and Chairman of the Board |
232,533 | $0 | 232,533 (Direct) |
View |
| 2025-02-15 Option Award |
2025-02-19 5:16 pm |
N/A 2035-02-15 |
JOHNSON & JOHNSON | JNJ | Broadhurst Vanessa EVP, Global Corp Affairs |
27,114 | $0 | 27,114 (Direct) |
View |
| 2025-02-14 Exercise |
2025-02-18 9:46 pm |
2025-02-14 N/A |
JOHNSON & JOHNSON | JNJ | Schmid Timothy EVP, WW Chair, MedTech |
2,806 | $0 | 17,657 (Direct) |
View |
| 2025-02-14 Tax Withholding |
2025-02-18 9:46 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Schmid Timothy EVP, WW Chair, MedTech |
1,015 | $156.71 | 17,657 (Direct) |
View |
| 2025-02-13 Exercise |
2025-02-18 9:33 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Schmid Timothy EVP, WW Chair, MedTech |
3,293 | $0 | 17,653 (Direct) |
View |
| 2025-02-14 Tax Withholding |
2025-02-18 9:33 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Schmid Timothy EVP, WW Chair, MedTech |
639 | $156.71 | 17,653 (Direct) |
View |
| 2025-02-14 Tax Withholding |
2025-02-18 9:33 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Schmid Timothy EVP, WW Chair, MedTech |
193 | $155.26 | 17,653 (Direct) |
View |
| 2025-02-13 Exercise |
2025-02-18 9:16 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief TO and Risk Officer |
8,625 | $0 | 96,500 (Direct) |
View |
| 2025-02-18 Tax Withholding |
2025-02-18 9:16 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief TO and Risk Officer |
200 | $156.15 | 96,500 (Direct) |
View |
| 2025-02-14 Tax Withholding |
2025-02-18 9:16 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief TO and Risk Officer |
2,873 | $156.71 | 96,500 (Direct) |
View |
| 2025-02-14 Tax Withholding |
2025-02-18 9:16 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief TO and Risk Officer |
223 | $155.26 | 96,500 (Direct) |
View |
| 2025-02-13 Exercise |
2025-02-18 9:13 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO |
23,080 | $0 | 90,669 (Direct) |
View |
| 2025-02-18 Tax Withholding |
2025-02-18 9:13 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO |
768 | $156.15 | 90,669 (Direct) |
View |
| 2025-02-14 Tax Withholding |
2025-02-18 9:13 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO |
7,805 | $156.71 | 90,669 (Direct) |
View |
| 2025-02-14 Tax Withholding |
2025-02-18 9:13 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO |
507 | $155.26 | 90,669 (Direct) |
View |
| 2025-02-15 Exercise |
2025-02-18 9:11 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | REED JOHN C EVP, Innovative Medicine, R&D |
1,350 | $0 | 18,240 (Direct) |
View |
| 2025-02-18 Tax Withholding |
2025-02-18 9:11 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | REED JOHN C EVP, Innovative Medicine, R&D |
385 | $156.15 | 18,240 (Direct) |
View |
| 2025-02-13 Exercise |
2025-02-18 9:08 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WWC. Innovative Medicine |
22,414 | $0 | 182,503 (Direct) |
View |
| 2025-02-18 Tax Withholding |
2025-02-18 9:08 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WWC. Innovative Medicine |
651 | $156.15 | 182,503 (Direct) |
View |
| 2025-02-14 Tax Withholding |
2025-02-18 9:08 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WWC. Innovative Medicine |
9,259 | $156.71 | 182,503 (Direct) |
View |
| 2025-02-14 Tax Withholding |
2025-02-18 9:08 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WWC. Innovative Medicine |
410 | $155.26 | 182,503 (Direct) |
View |
| 2025-02-13 Exercise |
2025-02-18 9:06 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Swanson James D. EVP, CIO |
6,018 | $0 | 20,280 (Direct) |
View |
| 2025-02-18 Tax Withholding |
2025-02-18 9:06 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Swanson James D. EVP, CIO |
141 | $156.15 | 20,280 (Direct) |
View |
| 2025-02-14 Tax Withholding |
2025-02-18 9:06 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Swanson James D. EVP, CIO |
1,447 | $156.71 | 20,280 (Direct) |
View |
| 2025-02-14 Tax Withholding |
2025-02-18 9:06 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Swanson James D. EVP, CIO |
152 | $155.26 | 20,280 (Direct) |
View |
| 2025-02-13 Exercise |
2025-02-18 9:05 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Mulholland Kristen EVP, Chief HR Officer |
3,438 | $0 | 15,366 (Direct) |
View |
| 2025-02-18 Tax Withholding |
2025-02-18 9:05 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Mulholland Kristen EVP, Chief HR Officer |
120 | $156.15 | 15,366 (Direct) |
View |
| 2025-02-14 Tax Withholding |
2025-02-18 9:05 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Mulholland Kristen EVP, Chief HR Officer |
747 | $156.71 | 15,366 (Direct) |
View |
| 2025-02-14 Tax Withholding |
2025-02-18 9:05 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Mulholland Kristen EVP, Chief HR Officer |
141 | $155.26 | 15,366 (Direct) |
View |
| 2025-02-13 Exercise |
2025-02-18 9:03 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Forminard Elizabeth Executive VP, General Counsel |
3,815 | $0 | 13,475 (Direct) |
View |
| 2025-02-18 Tax Withholding |
2025-02-18 9:03 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Forminard Elizabeth Executive VP, General Counsel |
307 | $156.15 | 13,475 (Direct) |
View |
| 2025-02-14 Tax Withholding |
2025-02-18 9:03 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Forminard Elizabeth Executive VP, General Counsel |
731 | $156.71 | 13,475 (Direct) |
View |
| 2025-02-14 Tax Withholding |
2025-02-18 9:03 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Forminard Elizabeth Executive VP, General Counsel |
215 | $155.26 | 13,475 (Direct) |
View |
| 2025-02-13 Exercise |
2025-02-18 9:02 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO and Chairman of the Board |
31,487 | $0 | 418,598 (Direct) |
View |
| 2025-02-18 Tax Withholding |
2025-02-18 9:02 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO and Chairman of the Board |
1,602 | $156.15 | 418,598 (Direct) |
View |
| 2025-02-14 Tax Withholding |
2025-02-18 9:02 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO and Chairman of the Board |
10,584 | $156.71 | 418,598 (Direct) |
View |
| 2025-02-14 Tax Withholding |
2025-02-18 9:02 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO and Chairman of the Board |
1,510 | $155.26 | 418,598 (Direct) |
View |